Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Find ways to quickly earn actual cash with various methods that fit your lifestyle. Start maximizing your income today.
23,852 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Four AI models project XRP’s 2026 end price in a wide band, signaling divergent bets on Ripple’s payment ambitions an...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
The SEC and CFTC jointly designate XRP as a digital commodity alongside Bitcoin and Ethereum, removing its security l...
Unanimity in board votes can mask risk. A fresh comparison to avalanche safety training shows why dissent matters for...
Analysts warn that Iran could use control of key internet cables as a new economic lever, risking a wave of volatilit...
Lawmakers unveil a bill to raise the ethanol blend to 15% year-round, hoping to shave pump costs and support farmers....
RLUSD just crossed $1.6B in market value as its use on the XRP Ledger expands. Yet the ripple for XRP itself remains ...
Bitcoin price craters $60,000 after the May U.S. jobs report, as traders reassess Federal Reserve easing bets. Crypto...
A crypto once riding high can crash hard. This guide lays out a practical plan to decide if you should hold, trim, or...
As the MiCA deadline approaches, smaller European crypto platforms face a choice between building a regulated stack o...
A Daiwa Securities analyst labeled SpaceX’s valuation catastrophic, while options traders bought calls, signaling a b...